Reference
Storrar N, et al. Apixaban is safe and effective thromboprophylaxis in myeloma patients treated with immunomodulatory therapy. Blood 130 (Suppl. 1): 1872, 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/1872 [abstract] - United Kingdom
Rights and permissions
About this article
Cite this article
Apixaban/thalidomide. Reactions Weekly 1695, 57 (2018). https://doi.org/10.1007/s40278-018-43884-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43884-9